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GlycoproteinThe entry of enveloped viruses involves attachment followed by close apposition of the viral and plasma
membranes. Then, either on the cell surface or in an endocytotic vesicle, the two membranes fuse by an
energetically unfavourable process requiring the destabilisation of membrane microenvironment in order to
release the viral nucleocapsid into the cytoplasm. The core fusion machinery, conserved throughout the
herpesvirus family, involves glycoprotein B (gB) and the non-covalently associated complex of glycoproteins
H and L (gH/gL). Both gB and gH possess several hydrophobic domains necessary for efﬁcient induction of
fusion, and synthetic peptides corresponding to these regions are able to associate to membranes and induce
fusion of artiﬁcial liposomes. Here, we describe the ﬁrst application of surface plasmon resonance (SPR) to
the study of the interaction of viral membranotropic peptides with model membranes in order to enhance
our molecular understanding of the mechanism of membrane fusion. SPR spectroscopy data are supported
by tryptophan ﬂuorescence, circular dichroism and electron spin resonance spectroscopy (ESR). We selected
peptides from gB and gH and also analysed the behaviour of HIV gp41 fusion peptide and the cationic
antimicrobial peptide melittin. The combined results of SPR and ESR showed a marked difference between
the mode of action of the HSV peptides and the HIV fusion peptide compared to melittin, suggesting that
viral-derived membrane interacting peptides all act via a similar mechanism, which is substantially different
from that of the non-cell selective lytic peptide melittin.al Medicine – II University of
9 081 5667646; fax: +39 081
. Galdiero).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Peptide–lipid interactions play a central role in various biological
processes, including the insertion and folding of membrane proteins,
the formation of ion channels, translocation of polypeptides through
membranes, the interaction of peptide hormones with membrane
receptors, signal transduction, the action of antimicrobial and
cytotoxic peptides, lipolysis and blood coagulation [1–3]. Subtle
differences in the relative afﬁnity of peptides for the phospholipids, as
well as the orientation and degree of insertion of the peptide into the
lipid bilayer, contribute to the biological function of these molecules
and may also play a role in the recruitment and assembly of signalling
complexes. The common structural feature of membrane-activepeptides and proteins is the adoption of a stable secondary structure
upon binding to the membrane surface.
Elucidation of the mechanism of membrane fusion for enveloped
viruses has attracted considerable attention because of its relative
simplicity and potential clinical importance [4,5]. The nature of the
interaction of viral fusion proteins with membranes and the
mechanism by which these proteins accomplish fusion are poorly
understood.
The entry of enveloped viruses involves attachment followed by
close apposition and fusion of the viral and plasma membranes. Then,
either on the cell surface or in an endocytotic vesicle, the two
membranes fuse by an energetically unfavourable process involving
the destabilisation of membrane microenvironment in order to
release the viral nucleocapsid into the cytoplasm. The fusion process
requires a major conformational change of the viral fusion protein to
expose a hydrophobic fusion peptide. This change can be induced by
virus envelope glycoproteins binding to cellular receptors at neutral
pH, and it occurs at the plasma membrane. Alternatively, the
conformational change of the fusion protein is induced by an acidic
580 S. Galdiero et al. / Biochimica et Biophysica Acta 1798 (2010) 579–591pH. In this case, virus particles undergo endocytosis prior to the
fusion.
Herpes simplex virus type I (HSV) enters cells by fusion of the
viral and host-cell membranes; however, the mechanisms underly-
ing the merging of these membranes are still unclear. Understanding
the molecular basis of the fusion process is of critical importance for
the design and development of therapeutic agents that could aid in
the treatment of HSV-related illnesses.
The core fusion machinery, conserved throughout the herpesvirus
family, involves glycoprotein B (gB) and the non-covalently associ-
ated complex of glycoproteins H and L (gH/gL) [6–8]. Although it is
now clear that both gB and gH play a fusogenic role in herpesviruses,
their precise mechanism of function is still unknown [7,8]. Based on
the crystal structure, gBwas proposed to be a fusion protein belonging
to the new class III together with vesicular stomatitis virus (VSV) G
protein and baculovirus gp64 [8,9]. However, gB does not function as a
fusion protein in the absence of gH/gL [7]. In fact in a transfection
model, only gH/gL is able to induce hemifusion while gB helps in
accomplishing complete fusion [10]. The structure of gH is still
unknown, but several indirect evidence suggest that this is a fusogenic
protein as well. Recently, it has been reported that both gB and gH
possess several hydrophobic domains necessary for efﬁcient induc-
tion of fusion, and synthetic peptides corresponding to these regions
are able to associate to membranes and induce fusion of artiﬁcial
liposomes [11–15].
Moreover, there is converging evidence that protein domains
other than the fusion peptide play an important and cooperative role
in inducing fusion between a viral envelope and a cell membrane. This
is particularly true for the complex fusionmechanism adopted by HSV
where at least two proteins, gB and gH, act in concert to gain access
into the cells.
Thus, it is likely that different protein domains cooperate in driving
membrane fusion, but their membranotropic characteristics may
differ, according to the role played by each single region.
The molecular details underlying the process of membrane fusion
due to fusion peptides are only just starting to be understood and the
role of numerous physicochemical parameters including peptide
charge, hydrophobicity, amphipathicity and the degree of secondary
structure and the angle subtended by the polar face, in the
physicochemical interaction between viral peptides and the mem-
brane are being analysed by several groups [1–3,8,16].
A wide variety of biophysical techniques have been used to study
biomolecular–membrane interactions [17,18]. These techniques have
provided important information on speciﬁc structure–function rela-
tionships associated with peptide–membrane interactions. To under-
stand the role ofmembrane association in protein function it would be
necessary to analyse the energetics of binding and insertion of
peptides into the membrane, as well as to determine the correlation
between the membrane induced conformational changes and the
associated variation in the afﬁnity to the membrane during binding.
Hence, the complete characterization of the binding of fusion peptides
to lipid surfaces also requires the deﬁnition of a mechanism of the
interaction process and the determination of binding constants
associated with each step of the proposed mechanism. Concerning
this point, it is generally considered that the binding of membrane-
active peptides to lipid membranes occurs via at least a two-step
process [19,20]. Initially, the peptide binds electrostatically to the
membrane localising itself near the surface, and then it could relocate
on the surface or insert further into the hydrocarbon region of the
lipid membrane by hydrophobic interactions. Since the binding
reaction is very fast, it is quite difﬁcult to distinguish the two binding
steps and therefore it is a challenge to study this process using
conventional techniques.
In recent years, Surface Plasmon Resonance (SPR) spectroscopy
has become a widely used technique to study antibody–antigen,
DNA–DNA, DNA–protein, protein–protein and receptor–ligand inter-actions [21–23] and also to quantitate these interactions through the
measurement of kinetic rate constants and afﬁnity constants. SPR
spectroscopy has also been applied to the study of biomembrane-
based systems [24,25]. A few studies were reported on the interaction
of proteins or short peptides with phospholipid membranes. Most of
them utilised hybrid lipid monolayers (using HPA sensor chip)
[25,26], and only a few described the use of lipid bilayers (using the
L1 sensor chip) [27], which more closely resemble biological
membranes. Recently, Papo and Shai [28] have used monolayer and
bilayer phospholipid membranes in SPR experiments to differentiate
between pore-forming and non-pore-forming lytic peptides. More-
over, they showed that melittin formed pores only in zwitterionic
membranes, whereas both melittin and the antimicrobial peptide
magainin had a detergent-like effect on negatively charged mem-
branes, similar to what has been predicted by others using different
methods [29].
Here, we describe the ﬁrst application of SPR to the study of the
interaction of fusion peptides with model membranes in order to
enhance our molecular understanding of the mechanism of viral-
induced membrane fusion. The analysed peptides were selected from
HSV-1 gB and gH and compared to the behaviour of HIV gp41 fusion
peptide and the cationic antimicrobial peptidemelittin. Moreover, our
data are further supported by tryptophan ﬂuorescence and electronic
spin resonance spectroscopy. In particular, both the experimentswere
meant to gain deeper insight into the positioning of the peptides in
lipid membranes, which is known to be crucial for their functionality
[30–33].
2. Materials and methods
2.1. Materials
Fluorenylmethoxycarbonyl (Fmoc) protected amino acids were
purchased from INBIOS (Pozzuoli, NA, Italy), NovaSyn TGA resin from
Nova Biochem (Darmstadt, Germany). The reagents (piperidine,
pyridine) for the solid-phase peptide synthesis were purchased from
Fluka (Sigma-Aldrich,Milano, Italy), triﬂuoroacetic acid (TFA) andacetic
anhydride were from Applied Biosystem (Foster City, CA, USA). H2O,
DMF and CH3CN were supplied by LAB-SCAN (Dublin, Ireland).
Dichloromethane and methanol, HPLC-grade solvents, were obtained
from Merck (Darmstadt, Germany). Egg phosphatidylcholine (PC),
cholesterol (Chol) and the ﬂuorescent probes N-(7-nitro-benz-2-oxa-
1,3-diazol-4-yl) phosphatidylethanolamine (NBD-PE), N-(Lissamine-
rhodamine-B-sulfonyl)phosphatidylethanolamine (Rho-PE), 6,7 Br-PC,
9,10 Br-PC and 11,12 Br-PC were purchased from Avanti Polar Lipids
(Birmingham, AL). Triton X-100 was obtained from Sigma (St. Louis,
MO). All other reagents were of analytical grade. The spin-labelled
phosphatidylcholine (1-acyl-2-[n-(4,4-dimethyloxazolidine-N-oxyl)]
stearoyl-sn-glycero-3-phosphocholine, n-PCSL) with the nitroxide
group at different positions, n, in the sn-2 acyl chain was also obtained
from Avanti Polar Lipids. The spin-labels were stored at −20 °C in
ethanol solutions at a concentration of 1 mg/ml.
2.2. Peptide synthesis
Peptides were synthesised by a solid-phase method using the
Fmoc strategy and subsequently puriﬁed as previously reported [12].
The puriﬁed peptides were shown to be homogeneous (>98%) by
analytical HPLC. The peptides were further subjected to electrospray
mass spectroscopy to conﬁrm their molecular weight. Peptide
sequences are reported in Table 1.
2.3. Preparation of liposomes
Large unilamellar vesicles (LUVs) consisting of PC/Chol (55/45 w/
w), andwhen necessary containing Rho-PE andNBD-PE, were prepared
Table 1
Peptide sequences.
Name Sequence
HSV peptides
gH626–644 GLASTLTRWAHYNALIRAF
gH776–802 STALLLFPNGTVIHLLAFDTQPVAAIA
gB168–186 VTVSQVWFGHRYSQFMGIF
gB632–650 PCTVGHRRYFTFGGGYVYF
Control peptides
gp41-FP AVGIGALFLGFLGAAGSTMGARS
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ
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100 mMNaCl, pH 7.4. Lipidswere dried froma chloroform solutionwith
a nitrogen gas stream and lyophilized overnight. For ﬂuorescence
experiments, dry lipid ﬁlms were suspended in buffer by vortexing;
then the lipid suspensionwas freeze–thawed6 times and then extruded
20 times through polycarbonate membranes with 0.1 μm diameter
pores to produce large unilamellar vesicles.
Small unilamellar vesicles (SUVs) were prepared by sonication of
PC/Chol (55/45 w/w) dispersions as previously described [35]. Brieﬂy,
dry lipid mixtures were dissolved in a CHCl3/MeOHmixture (2/1 v/v).
The solvents were then evaporated under a stream of nitrogen, and the
lipids were subjected to a vacuum for at least 3 h and then resuspended
in PBS buffer by vortexing. The resulting lipid dispersions were then
sonicated for 10 min in a bath-type sonicator until clear.
Multilamellar vesicles (MLVs) of PC/Chol (55/45 w/w) to be used
for ESR experiments were prepared bymixing appropriate amounts of
solutions of PC in dichloromethane/methanol (2/1 v/v), Chol in
chloroform, and spin-label solutions were mixed in small glass tubes.
In all samples, the spin-label was 1% by weight of the total lipid
mixture. A thin ﬁlm of the lipid was produced by evaporating the
solvent with a nitrogen gas stream. Final traces of solvent were
removed by subjecting the sample to vacuum desiccation for at least
3 h. The samples were then hydrated with the appropriate buffer and
vortexed.
2.4. Lipid mixing assays
Membrane lipid mixing was monitored using the resonance
energy transfer assay (RET) reported by Struck et al. [36]. The assay
is based on the dilution of the NBD-PE (donor) and Rho-PE (acceptor).
Dilution due to membrane mixing results in an increase in NBD-PE
ﬂuorescence. Thus, we monitored the change in donor emission as
aliquots of peptides were added to vesicles. Vesicles containing
0.6 mol% of each probe were mixed with unlabelled vesicles at a 1:4
ratio (ﬁnal lipid concentration, 0.1 mM). Small volumes of peptides in
dimethylsulfoxide (DMSO) were added; the ﬁnal concentration of
DMSO in the peptide solution was no higher than 2%. The NBD
emission at 530 nm was followed with the excitation wavelength set
at 465 nm. A cut off ﬁlter at 515 nmwas used between the sample and
the emission monochromator to avoid scattering interferences. The
ﬂuorescence scale was calibrated such that the zero level corre-
sponded to the initial residual ﬂuorescence of the labelled vesicles and
the 100% value corresponding to complete mixing of all lipids in the
system was set by the ﬂuorescence intensity of vesicles upon the
addition of Triton X-100 (0.05% v/v) at the same total lipid
concentrations of the fusion assay. All ﬂuorescence measurements
were conducted in PC/Chol (55/45) LUVs. Lipid mixing experiments
were repeated at least three times and results were averaged.
2.5. Binding analysis by surface plasmon resonance (SPR)
SPR experiments were carried out with a BIAcore 3000 analytical
system (Biacore, Uppsala, Sweden) using HPA and L1 sensor chips.The HPA sensor chip contains hydrophobic alkanethiol chains, which
are covalently bound to its gold surface, and a lipid heteromonolayer
is created by introducing liposomes to the chip; the complete
coverage of the surface with a polar lipid monolayer generates a
membrane-like environment where analytes in aqueous buffer
interact with a lipid monolayer [37]. The L1 sensor chip contains
hydrophobic alkanethiol chains, with exposed polar headgroups, and
a lipid bilayer is being created by introducing liposomes to the chip.
The experimental protocol was previously described by Mozsolits et
al. [25]. The running buffer used for all experiments was PBS (pH 7.4);
the washing solution was 40 mM N-octyl β-D-glucopyranoside. All
solutions were freshly prepared, degassed, and ﬁltered through
0.22 μm pores. The operating temperature was 25 °C. After cleaning
as indicated by the manufacturers, the BIAcore X instrument was left
running overnight using Milli-Q water as eluent to thoroughly wash
all liquid-handling parts of the instrument. The HPA (or L1) chip was
then installed, and the alkanethiol surface was cleaned by an injection
of the nonionic detergent N-octyl β-D-glucopyranoside (25 μl,
40 mM) at a ﬂow rate of 5 μl/min. PC/Chol (55/45 w/w) SUVs
(80 μl, 0.5 mM) were then applied to the chip surface at a ﬂow rate of
2 μl/min. To remove any multilamellar structures from the lipid
surface, we used NaOH 10 mM and increased the ﬂow rate to 50 μl/
min, which resulted in a stable baseline corresponding to the lipid
monolayer (or bilayer in the case of L1) linked to the chip surface. The
negative control BSA was injected (25 μl, 0.1 mg/μl in PBS) to conﬁrm
complete coverage of the nonspeciﬁc binding sites. Peptide solutions
(30 μl at a ﬂow rate of 5 μl/min) were injected onto the lipid surface.
PBS alone then replaced the peptide solution for 15 min to allow
peptide dissociation. SPR detects changes in the reﬂective index of the
surface layer of peptides and lipids in contact with the sensor chip. A
sensorgram is obtained by plotting the SPR angle against time. This
change in the angle is then translated to response units. Analysis of
the peptide–lipid binding event was performed from a series of
sensorgrams collected at different peptide concentrations.
The sensorgrams for each peptide–lipid interaction were analysed
by curve ﬁtting using numerical integration analysis [38]. The BIA
evaluation was used to perform complete kinetic analyses of the
peptide sensorgrams. Several curve ﬁtting algorithms were used but
good ﬁt was obtained only with the two-state reaction model, which
was previously used for describing the possible binding mechanisms
of antimicrobial peptides [19]. The data were ﬁtted globally by
simultaneously ﬁtting the sensorgrams obtained at different peptide
concentrations and the two-state reaction model was applied to each
data set. This model describes two reaction steps [25] which, in terms
of peptide–lipid interaction, may correspond to i) peptide (P) binds to
lipids (L) to give PL and ii) the complex PL changes to PL*, which
cannot dissociate directly to P+L and which may correspond to
partial insertion of the peptide into the lipid bilayer.
P + L⇌
Ka1
kd1
PL⇌
ka2
kd2
PL*:
The corresponding differential rate equations for this reaction
model are represented where RU1 and RU2 are the response units for
the ﬁrst and second steps, respectively, CA is the peptide concentra-
tion, RUmax is the maximum peptide binding capacity (or equilibrium
binding response), and ka1, kd1, ka2, and kd2 are the association and
dissociation rate constants for the ﬁrst and second steps, respectively.
dRU1 = dt = ka1 × CA × RUmax−RU1−RU2ð Þ−kd1 × RU1−ka2 × RU1 + kd2 × RU2
ð1Þ
dRU2 = dt = ka2 × RU1−kd2 × RU2: ð2Þ
While ka1 has M−1 s−1 units, kd1, ka2, and kd2 have s−1 units; thus
the total afﬁnity constant for the all process, KA, has M−1 units. Kinetic
Fig. 1. Peptide-promoted membrane fusion of PC/Chol (1:1) LUVs as determined by
lipid mixing; peptide aliquots were added to 0.1 mM LUVs, containing 0.6% NBD and
0.6% Rho. The increase in ﬂuorescence was measured after the addition of peptide
aliquots; reduced Triton X-100 (0.05% v/v) was referred to as 100% of fusion.
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model ﬁtting and the signiﬁcance of a parameter assessed by standard
deviations. The quality of the ﬁt to a speciﬁc parameter was deemed
signiﬁcant if the standard deviation was less than 10%. Except where
speciﬁcally indicated, all parameter values were signiﬁcant to the ﬁt.
2.6. Tryptophan ﬂuorescence experiments
Tryptophan is sensitive to its environment and has been
previously utilised to evaluate peptide localization in the membrane.
Emission spectra of the peptides containing at least one tryptophan
residue (gH626–644, and gB168–186) in the absence or presence of
target vesicles (PC/Chol=55/45) were recorded between 300 and
400 nm with an excitation wavelength of 295 nm.
Br-PC employed as quencher of tryptophan ﬂuorescence is suitable
for probing membrane insertion of peptides, since it acts over a short
distance and does not drastically perturb the membrane [39,40].
Peptides, containing the tryptophan residue, were added (ﬁnal
concentration of 0.5 μM) to 2 ml of buffer (5 mM HEPES, 100 mM
NaCl pH 7.4) containing 20 μl (50 mM) of Br-PC/Chol SUV, thus
establishing a lipid:peptide molar ratio of 100:1. After a 2 min
incubation at room temperature, an emission spectrum of the
tryptophan was recorded with excitation set at 295 nm. SUV
composed of PC/Chol (55/45) and which contained 25% of either
6,7 Br-PC, or 9,10 Br-PC or 11,12 Br-PC were used. Three separate
experiments were conducted for each peptide. In control experi-
ments, peptides in PC/Chol (55/45) SUVs without Br-PC were used.
2.7. ESR spectroscopy
For ESR experiments, the suspension of PC/Chol (55/45) MLVs
containing 1% by weight of a spin-labelled lipid, n-PCSL (n=5,7,10,14),
was transferred to a 100 μl glass capillary and pelleted in a tabletop
centrifuge. Excess supernatantwas removedand the capillarywasﬂame
sealed. Samples containing the peptides were prepared in a similar
manner, except that the lipid ﬁlm was hydrated directly with the
peptide solution in buffer. The lipid:peptide mole ratio was set to 10:1.
ESR spectra of lipid and lipid/peptide samples were recorded on a 9-
GHz Bruker Elexys E-500 spectrometer, at 25 °C, using procedures and
instrument setting reported in literature [41].
2.8. Circular dichroism measurements
CD spectra were recorded using a Jasco J-715 spectropolarimeter
in a 1.0 or 0.1 cm quartz cell at room temperature. The spectra are an
average of 3 consecutive scans from 260 to 195 nm, recorded with a
band width of 3 nm, a time constant of 16 s and a scan rate of 10 nm/
min. Spectra were recorded and corrected for the blank. Mean
residues ellipticities (MRE) were calculated using the equation Obsd/
lcn, where Obsd is the ellipticities measured in millidegrees, l is the
length of the cell in centimetres, c is the peptide concentration in
moles per litre, and n is the number of amino acid residues in the
peptide. Solutions of peptides in SUVs (0.1 mM) were prepared as
reported previously [11]. The peptide lipid ratios at which the
experiments were performed is 0.1 and 0.5 (mole/mole).
3. Results
3.1. Selection of peptides
In order to investigate the mode of action of membranotropic
peptides derived from the two HSV glycoproteins involved in the
membrane fusion process (gB and gH), we have selected two peptides
for each glycoprotein. For the glycoprotein H, the following peptides
have been selected: gH626–644, the putative internal fusion peptide
of gH [11]; and gH776–802, corresponding to the pre-transmembranedomain [12]. The two peptides that have been selected for the
glycoprotein B were shown in a previous work [15] to have the
highest fusion activity as well as inhibitory activity; in particular,
gB168–186 corresponds to one of the two fusion loops predicted from
the analysis of the crystallographic structure [9] while the other
peptide gB632–650 is located in the most hydrophobic C-terminal
domain of gB. A shorter version of this latter peptide, namely gB636–
650, has been recently conﬁrmed to have antiviral activity [42].
In our experiments we also used two control peptides: melittin
and HIV fusion peptide (gp41-FP). In particular, melittin is the major
component of the venom of the honey bee Apis mellifera and has been
extensively characterised by other groups [43]. On the other hand, the
fusion peptide of HIV [44], which has never been analysed by SPR, has
been chosen in order to compare our data with those obtained for a
well-known viral fusion peptide.
3.2. Fusogenic ability of peptides
The fusogenic activity of the HSV peptides has been reported
previously [11,12,15]. Here, we compare the fusion activity obtained
for the HSV peptides in PC/Chol 55/45 with that obtained for the
control peptides melittin and gp41-FP; this comparison is necessary
since the fusion activity of melittin and gp41-FP has never been
reported in the experimental condition used for HSV peptides. The
fusion activity has been determined by their ability to cause lipid
mixing of large unilamellar vesicles (LUVs). A population of LUVs
labelled with both NBD-PE and Rho-PE was mixed with a population
of unlabelled LUVs in the presence of increasing concentrations of
peptides. Fusion between the labelled and unlabelled vesicles caused
by the peptides results in dilution of the labelled lipids and therefore
reduced energy transfer between NBD-PE and Rho-PE. This change
can be visualised as an increase of NBD ﬂuorescence.
We already discussed in a previous paper [15] that although the
use of peptide fragments might not mimic the properties of the intact
protein, peptide studies give an indication of the relative propensities
of the different domains implicated in the fusion process. Fig. 1 shows
the results obtained for all the peptides used in this paper. In
particular, gB632–650 andmelittin already show a high fusion activity
at the lowest peptide to lipid ratio tested ([Peptide]/[Lipid]=0.05,
fusion of 20–25%) (mole/mole), while the other four peptides all
show a lower activity at the same ratio. Among the other four
peptides, gH626–644 and gp41-FP considerably increase their
fusogenic activity at higher peptide concentrations and reach high
fusion levels at a peptide/lipid ratio of 0.5. It is noteworthy that
gB168–186, one of the two N-terminal fusion loops of the
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peptides. This result might be due to the fact that this loop acts as a
part of a bipartite fusion domain to induce fusion.
3.3. Binding afﬁnity of the peptides to lipid monolayers and bilayers
measured by SPR
We utilised a BIAcore biosensor method to investigate the mode of
action of membranotropic peptides.
PC/Chol monolayers and bilayers were absorbed onto the HPA and
L1 chips, respectively. Sensorgrams of the binding of all the peptides
are shown in Figs. 2 and 3. The sensorgrams revealed that the RU
signal intensity increased as a function of the peptide's concentration.
This indicates that the amount of peptide bound to the lipids isFig. 2. Sensorgrams of the binding of gH626–644 (A), gH776–802 (B), gB168–186 (C), gBproportional to the peptide concentration. The sensorgrams of the
binding of melittin with lipid monolayers showed markedly lower
response levels as compared with its binding to bilayers. In contrast,
all the other peptides showed a similar response to monolayers as
compared to bilayers. The inspection of the shape of each sensorgram
reveals different binding kinetics with signiﬁcant differences both
among the peptides and between the two different lipid surfaces. In
particular, the sensorgrams obtained for the L1 chip indicate thatmost
of the peptides bind to the lipid surfaces in a biphasic manner. The
initial association starts as a fast process and then slows down
considerably towards the end of the peptide injection. The dissoci-
ation follows a similar pattern, with the signal falling rapidly at the
end of injection since the peptide is no longer present and the buffer
ﬂow removes a large amount of free or weekly bound peptide,632–650 (D), gp41-FP (E) and melittin (F) with the monolayers PC/Chol (HPA chip).
Fig. 3. Sensorgrams of the binding of gH626–644 (A), gH776–802 (B), gB168–186 (C), gB632–650 (D), gp41-FP (E) and melittin (F) with the bilayers PC/Chol (L1 chip).
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gB632–650, gp41-FP and melittin clearly indicate a change in the
association with a secondmuch slower association step evident in the
L1 chip compared to the HPA chip. Moreover, their sensorgrams did
not return to zero on the L1 chip, indicating that the peptides
remained signiﬁcantly bound to the surface or inserted into the hybrid
bilayer membrane.
We employed numerical integration analysis that uses nonlinear
analysis to ﬁt an integrated rate equation directly to the sensorgrams
[28]. When ﬁtting the peptide's sensorgrams globally (using different
concentrations of the peptides) with the simplest 1:1 Langmuir
binding model, a poor ﬁt was obtained (χ2>100), conﬁrming that
this model does not represent the lipid binding mechanism of all thepeptides investigated. However, a signiﬁcantly improved ﬁt was
obtained using numerical integration of the two-state reaction model
of the binding sensorgrams, suggesting that there is likely to be at
least two steps involved in the interaction between the peptide and
hybrid bilayer membrane surface. In analogy with previous studies of
peptide–membrane interactions using SPR [19], the ﬁrst step may
correspond to the actual binding of the peptide to the surface, and the
second step to the insertion of the peptide into the hydrophobic core
of the membrane. A set of peptide sensorgrams with different peptide
concentrations was used to estimate the kinetic parameters. The
average values for the rate constants obtained from the two-state
model analysis are listed in Tables 2 and 3 along with the afﬁnity
constant values (KA). The data in Tables 2 and 3, clearly indicate the
Table 2
Association (ka1, ka2) and dissociation (kd1, kd2) rate constants obtained for the HPA chip using the two-state model.
ka1 kd1 K1 ka2 kd2 K2 KA
gH626–644 (8.14±0.02)102 (4.39±0.05)10−2 1.8 104 (6.40±0.07)10−4 (2.13±0.04)10−4 3.0 7.42 104
gH776–802 (9.80±0.05)101 (6.77±0.02)10−2 1.4 103 (4.37±0.03)10−2 (5.83±0.08)10−3 7.5 2.42 104
gB168–186 (7.40±0.03)101 (3.81±0.03)10−3 1.9 104 (2.05±0.02)10−2 (1.65±0.01)10−2 1.2 4.35 104
gB632–650 (3.16±0.06)102 (5.73±0.03)10−3 5.5 104 (5.28±0.02)10−3 (1.71±0.01)10−3 3.1 2.25 105
Melittin (8.60±0.03)101 (7.93±0.01)10−3 1.1 104 (1.41±0.05)10−3 (1.83±0.09)10−3 0.8 1.92 104
gp41-FP (1.03±0.02)102 (5.69±0.01)10−3 1.8 104 (2.88±0.04)10−3 (1.18±0.05)10−4 24.4 4.62 105
The afﬁnity constants K1 and K2 are for the ﬁrst (K1=ka1/kd1) and for the second (K2=ka2/kd2) steps respectively, and the afﬁnity constant (KA) determined as (ka1/kd1)×(ka2/kd2)
is for the complete binding process. Standard deviations are reported in brackets.
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rate and slow dissociation rate of the ﬁrst step. If this step corresponds
to the electrostatic interaction, these results clearly indicate that
electrostatic forces play an important role in the binding of
membrane-active peptides.
Analysis of data reported in Tables 2 and 3 allowed several
important observations. The difference between the afﬁnity of the
peptides to HPA chips as compared to L1 chips should indicate the
contribution of the inner leaﬂet to the binding process [28,45–47]. In
fact, due to structural differences between supported monolayers
(HPA chip) and immobilised liposomes (L1 chip), it is possible to
differentiate between the surface adsorption and/or partial insertion
in the HPA chip and complete insertion into the hydrophobic core of
the membrane in the liposomes of the L1 chip. The values of the ratio
KA bilayer/KA monolayer, listed in Table 4, demonstrates that the binding
of melittin to bilayers is approximately 36-fold higher than to
monolayers, indicating that it is inserted deeply into the inner
membrane and thus supporting the pore-forming property of
melittin. Data obtained using the peptide melittin are in good
correlation with those reported by others [48,49]. In particular we
obtained a binding afﬁnity of approximately 104 with a higher afﬁnity
for the bilayer than the monolayer; our binding afﬁnities are slightly
lower than those previously reported [48,49] probably due to the
different lipid composition used in our study, which was selected
according to previous data collected by our group on HSV-1 peptides
induced fusion of liposomes [11].
The ﬁrst interesting observation is the different behaviour of HSV
peptides and of the HIV fusion peptide from the melittin, indicating a
differentmechanismof action. The values of the ratioKA bilayer/KA monolayer
(Table 4) demonstrate that the binding of the HSV peptides as well as the
HIV fusion peptide to monolayers, is similar to their binding to bilayers,
indicating that the peptides are not inﬂuenced by the membrane's inner
leaﬂet. Thus, our result supports the hypothesis that viral peptides equally
interact with the inner and outer leaﬂet stably inserting into the PC/Chol
membrane.
The analysis of binding constants reveals that the peptides gH776–
802 and gB168–186 are the ones with the lowest afﬁnity for both
bilayers and monolayers. gH776–802 represents a hydrophobic
peptide with membranotropic characteristics that has been derived
from the pre-transmembrane domain of gH, therefore, it is not
supposed to behave like canonical fusion peptides, instead it is
conceivable its putative activity in strengthening the interactionTable 3
Association (ka1, ka2) and dissociation (kd1, kd2) rate constants obtained for the L1 chip usin
ka1 kd1 K1
gH626–644 (5.23±0.09)102 (4.38±0.08)10−2 1.2 104
gH776–802 (4.2±0.01)101 (1.09±0.03)10−3 4.2 104
gB168–186 (4.83±0.09)102 (6.28±0.03)10−2 7.7 103
gB632–650 (9.9±0.02)101 (3.17±0.01)10−3 3.1 104
Melittin (4.85±0.02)103 (1.75±0.02)10−2 2.8 105
gp41-FP (3.2±0.07)101 (1.92±0.09)10−4 1.6 105
The afﬁnity constants K1 and K2 are for the ﬁrst (K1=ka1/kd1) and for the second (K2=ka2/k
is for the complete binding process. Standard deviations are reported in brackets.between opposing membranes during fusion. In this respect, the SPR
results demonstrate an involvement of this peptide in a superﬁcial
interaction with lipids, and this is further supported by the fact that
gH776–802 shows a comparable afﬁnity constant for the monolayer
and for the bilayer. gB168–186 is only a part of the bipartite fusion
peptide of gB, that is composed of two loops [9], and although
showing a signiﬁcant fusion activity and interaction with the bilayer
it's activity is lower than that of the other membrane interacting
peptides.
gp41-FP, gB632–650 and gH626–644 can be grouped as the
peptides with a higher binding constant for both monolayers and
bilayers. This result is of great importance because gp41-FP is the
well-known HIV-1 fusion peptide, gB632–650 is located in an outer β-
strand of domain IV of the glycoprotein gB, which contributes many of
the essential trimer contacts; and we previously reported [15] that it
has the features of a membranotropic peptide, while gH626–644 is a
putative internal fusion peptide of gH. The role of gH in fusion is still
debated and since a crystallographic structure is missing, the
recognition of further characteristics of gH626–644 could be valuable.
These ﬁndings, demonstrating a stable insertion of the gH peptide into
the membrane and complemented by previous data such as gH626–
644 ability to fuse liposomes with high efﬁciency, its plasticity, the
non accessibility to proteolitic cleavage once bound to membranes,
the amphipathic character, the high hydrophobicity and high α-
helical content determined by CD and NMR, makes of gH626–644 a
likely candidate as the most fusogenic region of gH [11,13,14].
The analysis of the results obtained for the peptide gB632–650, the
host hydrophobic C-terminal region of gB, demonstrates that also this
peptide behaves similarly to the HIV fusion peptide. In particular,
gB632–650 strongly binds to the vesicles and at the highest
concentration used it irreversibly binds to both the monolayer and
the bilayer. In the sensorgrams obtained with the L1 chip we detect a
strong effect also at low concentrations, indicating a deep insertion of
the peptide inside the bilayer.
3.4. Tryptophan ﬂuorescence experiments
A tryptophan residue naturally present in the sequence of a
protein or a peptide can serve as an intrinsic probe for the localization
of the peptide within a membrane. Peptides gH626–644 and gB168–
186 contain a tryptophan residue in the middle of the sequence; in
particular it is the 9th residue in gH626–644 and the 7th residue ing the two-state model.
ka2 kd2 K2 KA
(2.41±0.02)10−3 (3.98±0.07)10−3 0.6 6.92 104
(2.73±0.02)10−4 (1.96±0.03)10−3 0.1 2.30 104
(3.77±0.04)10−3 (4.21±0.02)10−3 0.9 1.46 104
(4.85±0.01)10−3 (5.00±0.03)10−4 9.7 3.94 105
(3.55±0.04)10−3 (2.33±0.02)10−3 1.5 7.01 105
(1.11±0.02)10−5 (1.30±0.09)10−5 0.8 3.53 105
d2) steps respectively, and the afﬁnity constant (KA) determined as (ka1/kd1)×(ka2/kd2)
Table 4
Binding to bilayers versus monolayers.
Peptides Kbilayer/Kmonolayer
gH626–644 0.9
gH776–802 1.0
gB168–186 0.3
gB632–650 0.9
Melittin 36
gp41-FP 0.8
Table 5
Fluorescence intensity of peptides in bromolipid vesicles.
Peptides
Lipid gH626–644 gB168–186
PC/Chol 100 100
6,7-Br-PC/Chol 84±5 66±7
9,10-Br-PC/Chol 68±3 76±8
11,12-Br-PC/Chol 64±4 51±6
The ﬂuorescence is reported as a percentage of the ﬂuorescence in PC/Chol. Standard
deviations calculated on three independent measurements are reported.
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increases when the amino acid enters a more hydrophobic environ-
ment, and together with an increase in quantum yield, the maximal
spectral position is expected to be shifted toward shorter wavelengths
(blue shift). Fig. 4 shows the ﬂuorescence emission spectra of the
peptides gH626–644 and gB168–186 upon interaction with PC/Chol
vesicles. In both cases changes in the spectral properties of the
peptides were observed, suggesting that the tryptophan residue of the
two peptides is located in a less polar environment upon interaction
with lipids.
Furthermore, the position of the peptides inside the bilayer can be
investigated by measuring the relative quenching of the ﬂuorescence
of the trp residue by the probes 11,12-Br-PC, 9,10-Br-PC and 6,7-Br-
PC, which differ in the position of the quencher moiety along the
hydrocarbon chain and permit to establish the depth of the peptide in
the membrane by comparing the quenching results obtained with
each of them. 6,7-Br-PC is a better quencher for molecules near or at
the interface, while the other two are better probes for molecules
buried deeply in the membrane. With both peptides the largest
quenching of tryptophan ﬂuorescencewas observedwith 11,12-Br-PC
vesicles (Table 5). Slightly less quenching was observed with 9,10-Br-
PC, and 6,7-Br-PC. These results indicate that, upon binding to
vesicles, the peptides were inserted into the membrane bilayer.Fig. 4. Tryptophan ﬂuorescence spectra in buffer and in liposomes for gH626–644
(panel A) and gB168–186 (panel B).3.5. ESR investigation on the interactions between fusion peptides and
PC/Chol membranes
The ESR spectroscopy, by using spin-labelled substances (peptides
and/or lipids) has been proved to give substantial information on the
interaction between viral fusion peptides and lipid membranes
[32,33]. In the present work, the association of the four peptides
under investigation with lipid bilayers was investigated by analysing
changes in ESR spectra of spin-labelled lipids, as reported in the
literature for other peptides derived from viral fusion proteins
[41,50,51] as well as for classical water-soluble peripheral membrane
proteins [30,52–55]. The samples investigated were phosphatidyl-
choline spin-labelled at different positions, n, in the sn-2 chain (n-
PCSL, n=5, 7, 10, 14) incorporated in PC/Chol membranes (55/45 w/
w), in the presence of the peptides. Preliminarily, the spectra in the
absence of the peptides were also registered. Inspection of Fig. 5
shows that all the spectra present a clearly deﬁned axially anisotropic
lineshape, an evidence that, due to the high cholesterol content, the
PC/Chol bilayer is in the liquid-ordered state [56]. In an attempt to
quantitatively analyse the spectra, the order parameter, S, was
calculated according to the relation [57]:
S =
T∥−T⊥ð Þ
Tzz−Txxð Þ
aN
a′N
ð3Þ
where T∥ and T⊥ are two phenomenological hyperﬁne splitting
parameters which can be determined experimentally for each spin-
labelled phospholipid as shown in Fig. 5 (note that 2T '⊥=2T⊥−1.6)
[58]. Txx and Tzz are the principal elements of the real hyperﬁne
splitting tensor in the spin Hamiltonian of the spin-label, which can be
measured from the corresponding single-crystal ESR spectrum and
are reported in the literature (Txx=6.1 G and Tzz=32.4 G) [59]. aN
and a'N are the isotropic hyperﬁne coupling constants for the spin-
label in crystal state and in the membrane, respectively, given by:
aN =
1
3
Tzz + 2Txxð Þ
a′N =
1
3
T∥ + 2T⊥ð Þ
The isotropic hyperﬁne coupling constant is an index of the
micropolarity experienced by the nitroxide, and the aN/a'N ratio in
Eq. (3) corrects the order parameter for polarity differences between
the crystal state and the membrane. Both S and a'N decrease
progressively with increasing n, as the spin-label position is stepped
down the chain toward the center of the membrane, see Fig. 6. The S
variation is an evidence of the ﬂexibility gradient in segmental chain
mobility [32,60], indicating that the lipid bilayer presents a relatively
rigid surface and rigid interior [61–63]. The a'N decrease is related to
the polarity gradient [33], indicating that the hydrophobicity
increases as the nitroxide group moves to the center of the bilayer.
Association of peptides to the lipid bilayer causes a signiﬁcant
variation in the ESR spectra of spin-labelled phospholipids. As an
example, Fig. 5 gives the ESR spectra of n-PCSL in PC/Chol bilayer
Fig. 5. ESR spectra of n-PCSL positional isomers in PC/Chol membranes in presence
(solid line) and absence (dashed line) of gH626–644.
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peptide molar ratio of 10/1. The presence of the gH626–644 induces
slight but signiﬁcant changes in the spin-label ESR spectra, which are
mainly detectable from the low- and high-ﬁeld component position
and lineshape.
In an attempt to quantify these evidence, the S and a'N values were
determined. Fig. 6 shows the dependence of these parameters on
chain position, n, for the n-PCSL spin-labels in PC/Chol membranes, in
the absence and in the presence of the peptides. In all cases, the
ﬂexibility and polarity gradients with the chain position of the lipid
bilayer membranes are preserved. Concerning a'N, it appears that its
value is only marginally affected by the peptides, i.e., no evident
variation in the local polarity is detectable. In contrast, inspection of
panel A of the ﬁgure reveals signiﬁcantly different behaviour of the
lipid chain mobility in the presence of the various peptides. In the
same ﬁgure the S variation with respect to the value determined in
the absence of any peptide, ΔS, is also reported. In the case of gH776–
802, addition of a peptide does not signiﬁcantly affect the S value at
any chain position. In the case of gB168–186, ΔS decreases – almost
tending to zero – with increasing n. gH626–644 causes an increase in
S to a comparable extent at all chain positions. The perturbations due
to gB632–650 increase with n. This indicates that the increase in lipid
packing density, which is induced by insertion of gH626–644, and
even more by that of gB632–650, propagates down the chain more
effectively than for the other peptides.
It is interesting to compare these results with those obtained for
the two reference peptides, namely gp41-FP and melittin. In the case
of gp41-FP, the spin-labels presenting the nitroxide group in position
n=5, 7, 10 present a clearly detectable S increase, as shown in Fig. 6.
Strikingly, for what concerns the spin-label presenting the nitroxide
in a deeper position, 14-PCSL, the presence of gp41-FP causes the
appearance of a second component in the ESR spectrum, see Fig. 7. The
second component is resolved in the outer wings of the spectrum and
corresponds to spin-labelled lipid chains whose motion is restricted.
This is a feature already encountered for all the peptides and proteins
which stably inserts in the lipid bilayer, such as integral membrane
proteins [30]. The slow motional component is due to spin-labelled
lipids participating to the “annular” structure surrounding the guestmolecule, while the ﬂuid component is due to relatively unperturbed
spin-labels in bulk lipid. Thus, we can conclude that gp41-FP deeply
inserts into the lipid bilayer. A similar experimental evidence has been
found by Curtain et al. for the same peptide in egg yolk phosphati-
dylcholine [33]. In this context, it is relevant to note that the same
authors, by analysing ESR spectra of spin-labelled gp41-FP in lipid
bilayers, concluded that the membrane-bound peptide could self-
aggregate [32].
In the presence of melittin, the S increases to a comparable extent
at all chain positions, similarly to that already reported in the
literature by using different lipid bilayers [64]. However, no second
component in the ESR spectra can be observed, at any n position of the
spin-label acyl chain. This evidence has been found in all cases where
peptides or proteins interact with the more external part of the
bilayer, inducing a lipid chain perturbation that propagates to the
inner part of the membrane [54]. Interestingly, similar results have
also been recently obtained for a peptide derived from the pre-
transmembrane region of the FIV gp36 glycoprotein, which induces a
destabilisation of lipid bilayers [41], thus supporting the view that ESR
alone is unable to discriminate between lytic and membranotropic
domains.
Concerning the peptides analysed in the present work, analysis of
Fig. 7 shows that, while gH626–644 only causes an enlargement of the
spacing between the two more external signals, i.e. an S increase, in
the case of gB632–650 the appearance of a shoulder at low ﬁeld and of
a broad minimum at high ﬁeld suggest a behaviour more similar to
that of gp41-FP. Thus, these experimental evidence indicate that
gH626–644 interacts with the lipid bilayer being located in the more
external part of it. In contrast, gB632–650 deeply penetrates in the
bilayer, stably inserting into its inner region.
3.6. Secondary structure of synthetic peptides
Since the structural conformation of peptides has been shown in
many cases to correlate with fusogenic activity, and to understand
whether secondary structure induction contributes to the initial
stages of peptide binding, the secondary structure of the four HSV
peptides and of the two control peptides in buffer and in PC/Chol 55/
45 SUVs was determined by CD spectroscopy (Fig. 8). As reported in
literature [44], fusion peptides may change their secondary structure
at different peptide/lipid ratios, in particular, they may show a beta
and/or oligomeric structure at high peptide/lipid ratios, while they
may assume an α-helical structure at low peptide/lipid ratios.
The secondary structuremeasurements for each peptide were thus
performed at two different peptide/lipid ratios; in particular, we used
a molar ratio of 0.1 (low peptide/lipid ratio) and a ratio of 0.5 (high
peptide/lipid ratio). The ratio of 0.5 was tested because in this
condition we could clearly evidence a high fusion activity for all the
peptides. All the spectra shown in Fig. 8 for the 6 peptides are
indicative of the formation of substantial secondary structure in PC/
Chol. The melittin shows an helical spectrum in buffer and at both
ratios withminima at 222 nm and 208 nm. The spectra for the peptide
gp41-FP is consistent with the formation of a predominantly β-sheet
conformation at high peptide/lipid ratios and an helical structure at
low peptide/lipid ratios, as already reported for this peptide at the
same ratios [44]. The spectra for the peptide gH626–644 is consistent
with a predominantly α-helical conformation. All the other peptides
show spectra consistent with a predominantly β-sheet conformation
in the condition tested.
4. Discussion
Peptide–membrane interactions play a central role in numerous
biological processes and are characterised by several complex and still
unknown steps. In fact, it is likely that membranotropic peptides
initially bind to the bilayer surface through mainly electrostatic
Fig. 6. Dependence on spin-label position, n, of the isotropic hyperﬁne coupling constant, a'N (panel A, left-hand ordinate), and of the order parameter, S (panel B, left-hand
ordinate), of the n-PCSL in PC/Chol in the absence (bold line) and in the presence of gH626–644 (□), gH776–802 (○), gB168–186 (△), gB632–650 (◊), melittin (▽) or gp41-FP( ).
T=25 °C. Variation of a'N (panel A, right-hand ordinate), and S (panel B, right-hand ordinate) with respect to the unperturbed bilayer, on adding gH626–644 (■), gH776–802 (●),
gB168–186 (▲), gB632-650 (♦), melittin (▼) or gp41-FP ( ) to the membrane.
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◢
⊿interactions, then assume a particular secondary structure and
eventually insert into the lipid membrane. The exact mechanism of
interaction is supposed to play a fundamental role in the activity of the
peptide. Conformational and binding properties represent key aspects
of the interaction that may help in understanding the factors that
contribute to the binding of membrane-active peptides to biomem-Fig. 7. ESR spectra of 14-PCSL positional isomers in PC/Chol membranes in the absence
(A) and presence of gH626–644 (B), gB632–650 (C) and gp41-FP (D). Arrows indicate
the position of the second, more immobilised, spectral component.branes. The present study demonstrates that SPR is a powerful tool for
investigating real-time interactions between membranotropic pep-
tides and lipid monolayers and bilayers, and as a result, allows
distinguishing between different modes of action. This is because it
allows continuous monitoring of two major steps: the initial
association to the membrane and the slower insertion into the
hydrophobic core.
We used four synthetic peptides corresponding to the known
membrane interacting regions of HSV fusion glycoproteins gH and gB,
namely gH626–644, gH776–802, gB168–186 and gB632–650. In
particular, gH626–644 has been previously identiﬁed as the putative
fusion peptide of gH [11,65,66], while gH776–802 corresponds to the
pre-transmembrane domain of gH and has been shown to interact
signiﬁcantly with liposomes and thus to be involved in the fusion
process [12]. gB168–186 of HSV gB has been identiﬁed by other
methodologies as a fusion peptide [9,15], while gB632–650 has also
been previously shown to interact with membranes and to have a
signiﬁcant inhibitory activity [15,42]. As control peptides we used the
fusion peptide of HIV and melittin, a cationic antimicrobial peptide;
the HIV fusion peptide was selected to determine the behaviour of a
peptide able to stably interact with membranes at a certain depth,
while melittin was selected as being responsible for the formation of
pores through the bacterial membrane. We followed the binding of
the peptides to both the monolayer and the bilayer membranes and
this allowed us to examine the contribution of the inner leaﬂet of the
membrane with regard to the binding properties of viral membrano-
tropic peptides. This approach was recently reported for discriminat-
ing between transmembrane pore formation versus membrane
perturbation.
The SPR data show a marked difference between the mode of
action of the HSV peptides and the HIV fusion peptide compared to
Fig. 8. Circular dichroism spectra of peptides in buffer and in PC/Chol at different peptide/lipid (mole/mole) ratios.
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all act via a similar mechanism, which is substantially different from
that of the non-cell selective lytic peptide melittin. Tables 2 and 3
show that for all the gH and gB peptides as well as the HIV fusion
peptide, there is almost no difference between the afﬁnity to
monolayers as compared to bilayers. This indicates that the outer
and inner leaﬂets equally participate in the binding, or in other words,
the peptides stably insert into the PC/Chol membrane but they are
unable to form pores. Thus, our results strongly suggest that all the
analysed peptides penetrate into the hydrophobic core of the
membrane at variable depths without forming pores and therefore
their fusion activity may be due to their insertion inside the bilayerwhich causes the perturbation of the packing of the lipids and a
differential surface area increase of the outer and inner membrane
leaﬂets which are responsible of starting the fusion process.
From the analysis of the data obtained for the various peptides, we
were able to better understand the different behaviour of membra-
notropic sequences. The peptide gH776–802 shows only a superﬁcial
interaction with the membranes, thus suggesting that it probably is
only marginally involved in the fusion process. This is consistent with
its putative support action in the overall fusion mechanism. The
peptide gB168–186 penetrates slightly into the membrane bilayer; its
fusion activity and the binding constants are lower than that of other
fusion peptides, the ﬂuorescence experiments show that the
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membrane bilayer, but ESR studies show a superﬁcial interaction of
the peptide with the membrane; its behaviour may be due to the
intrinsic properties of a bipartite fusion peptide, where only the
contemporary presence of both peptides is able to perturb the lipid
bilayers.
Nevertheless, the other two HSV peptides, namely gH626–644,
and gB632–650 strongly interact with both membrane models with
an afﬁnity constant similar to the one obtained for HIV gp41 fusion
peptide (gp41-FP). This novel result point to a clear distinction
between the behaviour of viral fusion peptides and other membrano-
tropic peptides. By ESR experiments, we were able to differentiate
between the three most active peptides: gH fusion peptide gH626–
644 and the gB peptides gB168–186 and gB632–650. In fact, gH626–
644 and even more evidently gB632–650 are able to deeply enter the
lipid bilayers similarly to gp41-FP.
There have been numerous structure studies on fusion peptides
but there is not yet a clear correlation between structure and
fusogenic activity; in particular, fusion peptide can adopt either
helical or β-strand conformation. An α-helix conformation has been
proposed to be associated with pore formation by peptides in vesicle
membranes [67,68], while the extended antiparallel β-structure of the
peptides was believed to be involved in the initial steps of the fusion
process, being likely to reside primarily at the lipid–water interface; in
most studies on viral fusion peptides an α-helical arrangement of the
lipid-bound peptide has also been suggested to represent the fusion-
active conformation [44,69]. CD data reveal that melittin can adopt an
α-helical conformation in all the experimental conditions that we
tested here and that the monomer/oligomer equilibrium is shifted
toward the oligomeric state; the peptide gH626–644 shows a high α-
helical content although it does not show oligomerization phenomena
in the condition tested here, while all the other peptides show a β-
structure. Our results favour the involvement of peptides in a β-
conformation in the actual fusion event, althoughwe cannot eliminate
the possibility that fusion peptides may adopt an α-helix conforma-
tion when more deeply inserted inside the bilayer. A dynamic
equilibrium between helix and non-helix forms of the fusion peptide
in the membrane environment appears thus to be essential for the
fusion process. The secondary structure of fusion peptides may be of
importance in the interaction with the membrane and involves both
electrostatic and hydrophobic effects; in fact, fusion peptides could be
adsorbed at the membrane interface and change their conformation
adopting a beta and/or aggregate structure as a consequence of the
different lipid headgroups present in the bilayer. Moreover when in
an helical conformation they could be inserted more deeply than the
membrane interface.
We have also shown that the combination of SPR and ESR is a
powerful tool to obtain real-time monitoring of the steps governing
themode of action of membrane-active peptides, some of which could
not be detected directly by other means. The SPR studies clearly
differentiate between the two steps involved in membrane binding
and permeation via the two general mechanisms, namely, pore
formation by melittin and membrane insertion for all the other
peptides. In this respect, it is outstanding that the Kbilayer/Kmonolayer
for melittin is very high compared to the others, clearly discriminating
the pore formation from other membrane insertion mechanisms that
may either involve an α-helix or a β-sheet conformation. Thus,
membrane location rather than conformation may discriminate
between fusion peptides and other membranotropic sequences.
Partial peptide insertion into the outer leaﬂet of the target cell
membrane would likely perturb the leaﬂet and lead to fusion.
To the best of our knowledge, this is the ﬁrst report that, using in
combination ESR and SPR, has been applied to study viral fusion
peptide interactions with membranes. Although afﬁnity constants
and lipid insertion capabilities are not the sole properties determining
the role of fusion peptides in viral proteins, it has been shown thatgH626–644, gB168–186, gB632–650 and gp41-FP have a similar
mechanism of interaction with lipids that is consistent with their
fusion peptide and/or membranotropic attributes. In particular,
gB168–186 does not interact with the hydrophobic core of the
membrane and translocates only slightly into the inner membrane via
interaction with the lipid head groups, therefore it may work in
cooperation with the second fusogenic loop in gB, and also with the
other gB peptide (gB632–650) and with gH (through the gH626–644
region and the other membranotropic sequences) to complete fusion.
Recent structural studies have described a new class III of viral
fusion proteins [9,70,71], and the three proteins belonging to this
class, all have shown to possess a bipartite fusion peptide, which is
composed of two hydrophobic loops at the tip of a four-strand β-sheet
region inserted on a pleckstrin-domain. The fusion loops of gB are not
buried at an oligomeric interface in the putative prefusion conforma-
tion, but cluster near the viral membrane. Moreover, any deep
penetration of the peptide gB168–186, one of the fusogenic loops,
inside the membrane is precluded by the presence of charged and
polar residues; probably the tryptophan and phenylalanine, present in
the loop, act as ﬁngers by positioning themselves at the interface
between the fatty acid chain and the head group layers of the lipids.
This interaction alone is not sufﬁcient to pull the target membrane
toward the viral one but may perturbate the outer leaﬂet of the target
bilayer facilitating the other membranotropic domains of gB and gH.
All the data available point to the fact that gB alone is not sufﬁcient for
viral entry, in fact all herpesviruses also require gH and gL. The
domain corresponding to gB632–650 plays a fundamental role in the
fusion process. Thus, the peptide gB632–650 is particularly interesting
because it presents a high inhibitory activity, a high fusion activity and
a high and stable penetration inside the membrane bilayer. This
peptide is located in domain IV of the protein which comprises two
discontinuous segments, residues 111–116 and 573–660, linked by a
disulﬁde bond, and contains the epitopes recognised by neutralising
antibodies. The fusion process of HSV is very complicated and we are
gaining information on the twomain proteins involved in the process,
with the aim to describe the mechanism by which gB and gH
cooperate to perform fusion. Our results provide some new elements
in the understanding of HSV fusion but still more work is necessary.
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